PT83255B - Polipeptidos e anticorpos, caracteristicos do polilomavirus e suas aplicacoes no diagnostico "in vitro" na pervencao e ou na luta contra as infeccoes por papilomavirus - Google Patents
Polipeptidos e anticorpos, caracteristicos do polilomavirus e suas aplicacoes no diagnostico "in vitro" na pervencao e ou na luta contra as infeccoes por papilomavirusInfo
- Publication number
- PT83255B PT83255B PT83255A PT8325586A PT83255B PT 83255 B PT83255 B PT 83255B PT 83255 A PT83255 A PT 83255A PT 8325586 A PT8325586 A PT 8325586A PT 83255 B PT83255 B PT 83255B
- Authority
- PT
- Portugal
- Prior art keywords
- infections
- polylomavirus
- papilomavirus
- polypeptides
- antibodies
- Prior art date
Links
- 238000003745 diagnosis Methods 0.000 title abstract 2
- 238000000338 in vitro Methods 0.000 title abstract 2
- 208000015181 infectious disease Diseases 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 241001631646 Papillomaviridae Species 0.000 abstract 2
- 208000009608 Papillomavirus Infections Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000523 sample Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/708—Specific hybridization probes for papilloma
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/01—DNA viruses
- G01N2333/025—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
- Y10S436/813—Cancer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Food Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8512750A FR2586428B1 (fr) | 1985-08-26 | 1985-08-26 | Polypeptides et anticorps, caracteristiques du papillomavirus et leurs applications au diagnostic in vitro, a la prevention et/ou la lutte contre des infections a papillomavirus |
Publications (2)
Publication Number | Publication Date |
---|---|
PT83255A PT83255A (en) | 1986-09-01 |
PT83255B true PT83255B (pt) | 1989-07-31 |
Family
ID=9322402
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT83255A PT83255B (pt) | 1985-08-26 | 1986-08-26 | Polipeptidos e anticorpos, caracteristicos do polilomavirus e suas aplicacoes no diagnostico "in vitro" na pervencao e ou na luta contra as infeccoes por papilomavirus |
Country Status (12)
Country | Link |
---|---|
US (3) | US5955260A (pt) |
EP (1) | EP0235187B1 (pt) |
JP (4) | JP2755574B2 (pt) |
AT (1) | ATE70280T1 (pt) |
CA (1) | CA1279276C (pt) |
DE (1) | DE3682893D1 (pt) |
DK (1) | DK172647B1 (pt) |
ES (1) | ES2003339A6 (pt) |
FR (1) | FR2586428B1 (pt) |
GR (1) | GR862201B (pt) |
PT (1) | PT83255B (pt) |
WO (1) | WO1987001375A1 (pt) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR930007580B1 (ko) * | 1986-03-21 | 1993-08-13 | 엥스띠뛰 빠스뙤르 | 유두종 비루스 게놈으로부터 유도된 결정 dna 서열, 그의 시험관내 진단 목적용 용도 및 항원 조성물의 제조 방법 |
DE3625257A1 (de) * | 1986-07-23 | 1988-02-04 | Behringwerke Ag | Expressionsprodukte der menschlichen papillomviren typ 16 und 18, fuer diese proteine spezifische antikoerper und diese antikoerper bzw. entsprechende dna enthaltende diagnostika |
FR2631341B1 (fr) * | 1988-05-13 | 1991-04-26 | Pasteur Institut | Sondes a papillomavirus hpv49, hpv50, hpv54, hpv55 et produits genetiquement et immunologiquement lies a ce papillomavirus hpv49, hpv50, hpv54, hpv55 et procede de diagnostic in vitro d'infections a papillomavirus et d'immunisation in vivo contre ces papillomavirus |
FR2632956B2 (fr) * | 1988-05-13 | 1991-07-12 | Pasteur Institut | Sondes a papillomavirus hpv49, hpv50, hpv54, hpv55; produits genetiquement et immunologiquement lies a ce papillomavirus hpv49, hpv50, hpv54, hpv55; procede de diagnostic in vitro d'infections a papillomavirus et d'immunisation in vivo contre ces papillomavirus |
SE8803870D0 (sv) * | 1988-10-28 | 1988-10-28 | Medscand Ab | Method for detection of human papillomavirus (hpv) for diagnostic purposes |
FR2641081A1 (pt) * | 1988-12-23 | 1990-06-29 | Medgenix Group | |
FR2656627B1 (fr) * | 1989-12-28 | 1992-04-17 | Pasteur Institut | Sonde a papillomavirus (hvpv63), notamment pour le diagnostic in vitro d'infections a papillomavirus, pouvant s'accompagner de neoplasies genitales, et produits genetiquement et immunologiquement lies a ce papillomavirus. |
FR2661921B1 (fr) * | 1990-05-11 | 1992-08-07 | Pasteur Institut | Sonde a papillomavirus (hpv66), notamment pour le diagnostic in vitro d'infections a papillomavirus, pouvant s'accompagner de neoplasies genitales, et produits genetiquement et immunologiquement lies a ce papillomavirus. |
SE9001705D0 (sv) * | 1990-05-11 | 1990-05-11 | Medscand Ab | Saett foer diagnostik av virusbaerande tumoerer genom immunoassay |
US5932412A (en) * | 1990-05-11 | 1999-08-03 | Euro-Diagnostica Ab | Synthetic peptides in human papillomaviruses 1, 5, 6, 8, 11, 16, 18, 31, 33 and 56, useful in immunoassay for diagnostic purposes |
SI0757717T1 (sl) * | 1994-05-16 | 2006-08-31 | Merck & Co Inc | Cepivo proti papilomavirusu |
GB9621091D0 (en) | 1996-10-09 | 1996-11-27 | Fondation Pour Le Perfectionem | Attenuated microorganisms strains and their uses |
GB9717953D0 (en) * | 1997-08-22 | 1997-10-29 | Smithkline Beecham Biolog | Vaccine |
AU2001251394A1 (en) * | 2000-04-05 | 2001-10-23 | Impact Diagnostics, Inc. | Immunological methodology for discerning human papillomavirus |
GB0011903D0 (en) * | 2000-05-18 | 2000-07-05 | Astrazeneca Ab | Combination chemotherapy |
CA2441947C (en) | 2001-03-23 | 2014-05-13 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Human papilloma virus immunoreactive peptides |
US6933123B2 (en) | 2001-04-05 | 2005-08-23 | Yao Xiong Hu | Peptides from the E2, E6, and E7 proteins of human papilloma viruses 16 and 18 for detecting and/or diagnosing cervical and other human papillomavirus associated cancers |
CA2551560A1 (en) * | 2003-12-23 | 2005-07-14 | Arbor Vita Corporation | Antibodies for oncogenic strains of hpv and methods of their use |
AU2005275050A1 (en) * | 2004-07-15 | 2006-02-23 | Mastercard International Incorporated | Reference equipment for testing contactless payment devices |
JP6046651B2 (ja) * | 2014-02-12 | 2016-12-21 | Necプラットフォームズ株式会社 | プログラム切替システム及びプログラム切替方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI64813C (fi) * | 1980-12-31 | 1984-01-10 | Ilkka Antero Palva | Foerfarande foer producering av ett utvalt aeggviteaemne och vid foerfarandet anvaenda rekombinantplasmidvektorer |
FR2524487B1 (fr) * | 1982-04-05 | 1985-11-22 | Pasteur Institut | Fragments d'adn codant pour des polypeptides contenant au moins un determinant antigenique des papillomavirus, notamment du type hpv 1a et polypeptides correspondants |
US4514508A (en) * | 1982-07-06 | 1985-04-30 | Biond Inc. | Assaying for a multiplicity of antigens or antibodies with a detection compound |
EP0133123A1 (en) * | 1983-07-25 | 1985-02-13 | Mgi Pharma, Inc. | Immunogens of papilloma viruses |
CA1276575C (fr) * | 1984-11-30 | 1990-11-20 | Sylvie Beaudenon | Sondes a papillomavirus et procede de diagnostic in vitro d'infections a papillomavirus |
JP2648303B2 (ja) * | 1985-04-04 | 1997-08-27 | ジョージタウン・ユニバーシティ | 型特異的乳頭腫ウイルスdna配列およびペプチド |
SE8803870D0 (sv) * | 1988-10-28 | 1988-10-28 | Medscand Ab | Method for detection of human papillomavirus (hpv) for diagnostic purposes |
-
1985
- 1985-08-26 FR FR8512750A patent/FR2586428B1/fr not_active Expired
-
1986
- 1986-08-22 EP EP86904851A patent/EP0235187B1/fr not_active Expired - Lifetime
- 1986-08-22 JP JP61504468A patent/JP2755574B2/ja not_active Expired - Lifetime
- 1986-08-22 WO PCT/FR1986/000288 patent/WO1987001375A1/fr active IP Right Grant
- 1986-08-22 DE DE8686904851T patent/DE3682893D1/de not_active Expired - Lifetime
- 1986-08-22 AT AT86904851T patent/ATE70280T1/de not_active IP Right Cessation
- 1986-08-25 ES ES8601326A patent/ES2003339A6/es not_active Expired
- 1986-08-26 GR GR862201A patent/GR862201B/el unknown
- 1986-08-26 PT PT83255A patent/PT83255B/pt unknown
- 1986-08-26 CA CA000516841A patent/CA1279276C/fr not_active Expired - Lifetime
-
1987
- 1987-04-24 DK DK198702089A patent/DK172647B1/da not_active IP Right Cessation
-
1995
- 1995-04-21 US US08/426,648 patent/US5955260A/en not_active Expired - Lifetime
- 1995-06-06 US US08/470,471 patent/US5919615A/en not_active Expired - Lifetime
- 1995-06-06 US US08/467,281 patent/US6010704A/en not_active Expired - Lifetime
-
1996
- 1996-04-30 JP JP8109988A patent/JP2818745B2/ja not_active Expired - Lifetime
-
1997
- 1997-10-15 JP JP28238597A patent/JP3294787B2/ja not_active Expired - Lifetime
-
1998
- 1998-04-22 JP JP10112334A patent/JP3067734B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CA1279276C (fr) | 1991-01-22 |
JP2755574B2 (ja) | 1998-05-20 |
FR2586428B1 (fr) | 1988-11-25 |
US5955260A (en) | 1999-09-21 |
FR2586428A1 (fr) | 1987-02-27 |
WO1987001375A1 (fr) | 1987-03-12 |
US6010704A (en) | 2000-01-04 |
ES2003339A6 (es) | 1988-11-01 |
DK208987A (da) | 1987-06-26 |
JPS63500662A (ja) | 1988-03-10 |
JP3067734B2 (ja) | 2000-07-24 |
EP0235187A1 (fr) | 1987-09-09 |
JPH10114677A (ja) | 1998-05-06 |
DK208987D0 (da) | 1987-04-24 |
GR862201B (en) | 1986-12-23 |
US5919615A (en) | 1999-07-06 |
JP3294787B2 (ja) | 2002-06-24 |
JPH1123577A (ja) | 1999-01-29 |
JPH08308597A (ja) | 1996-11-26 |
PT83255A (en) | 1986-09-01 |
DE3682893D1 (de) | 1992-01-23 |
ATE70280T1 (de) | 1991-12-15 |
EP0235187B1 (fr) | 1991-12-11 |
DK172647B1 (da) | 1999-04-06 |
JP2818745B2 (ja) | 1998-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT83255B (pt) | Polipeptidos e anticorpos, caracteristicos do polilomavirus e suas aplicacoes no diagnostico "in vitro" na pervencao e ou na luta contra as infeccoes por papilomavirus | |
ES8801318A1 (es) | Un procedimiento para la produccion de un peptido. | |
MY141641A (en) | Compositions comprising viruses and methods for concentrating virus preparations | |
IL137176A0 (en) | Antibodies to 4dr and uses thereof | |
ES2008974A6 (es) | Formulacion liquida de enzimas para aplicacion tecnica, utilizaciones y procedimientos de empleo para desencalado, adobo, remojo y desengrasado de pieles en tripa. | |
PT1062325E (pt) | Purificacao de preparacoes de virus | |
AU597698B2 (en) | Expression products of human papilloma virus type 18, antibodies specific to these proteins, and diagnostic aids containing these antibodies or corresponding DNA | |
IT8567140A1 (it) | Procedimento perfezionato per la produzione di proteine, particolarmente anticorpi, con l'impiego di mezzi ipertonici, e mezzo ipertonico per l'attuazione di tale procedimento. | |
HK185095A (en) | Papillomavirus probes (HPV49 HPV50 HPV54 HPV55) products genetically and immunologically related to this papillomavirus and in vitro methods for the diagnosis of papillomavirus infections and for the production of antibodies against these papillomaviruses | |
PT1149910E (pt) | Composicao farmaceutica contra os tumores e as infeccoes por papilomavirus | |
FR2445338A1 (fr) | Preparation de glycoproteine isolee d'enveloppes d'onco-rna virus et vaccins qui la contiennent | |
MX9703570A (es) | Proteinas de virus de papiloma purificadas. | |
EP0306219A3 (en) | Novel hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids | |
DE3884680D1 (de) | Äusseres Membranprotein F von Pseudomonas aeruginosa. | |
AU6920387A (en) | Molecular probes, process for preparation thereof, and applications including their use for determining the sex of embryos | |
ATE49976T1 (de) | Modifizierte adeninegruppe enthaltende sonde, ihre herstellung und verwendungen. | |
ES8704962A1 (es) | Un procedimiento para preparar 1b-d-ribofuranosil, 1-2-4-triazol-3-carboxamida. | |
ES2061566T3 (es) | Anticuerpos monoclonales contra la proteina e7 del papilomavirus humano tipo 16, procedimiento para su preparacion, asi como su empleo. | |
DE69929683D1 (de) | Antisense modulierung von lfa-3 | |
IT1218692B (it) | Procedimento microbiologico per la preparazione di 9 alfa-idrossi-4-androstene-3,17 dione | |
ES8506029A1 (es) | Un procedimiento para la preparacion de un compuesto | |
AU2459188A (en) | Anticoagulative protein pp4-x, and its preparation and use | |
CA2115136A1 (en) | Factor XIII Compositions | |
DE69323191D1 (de) | Wasserlösliche retinoide | |
SU702343A1 (ru) | Цифровой регул тор |